Concepedia

S.M. de Groot

SD

Statistics

Publications

3

Citations

231

H-Index

3

Active since

2013

Affiliations

Erasmus MC Cancer Institute(Current)

Reinier de Graaf Hospital

Franciscus Vlietland

Leiden University Medical Center

The Netherlands Cancer Institute

S.M. de Groot is an author at Erasmus MC Cancer Institute specializing in chemotherapy, oncology, and metastatic breast cancer treatment.

Publications per year

2013–2014

3

Publications

3

Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group

Marije E. Hamaker, Caroline Seynaeve, A.N.M. Wymenga et al. · The Breast · 2013 · 137 citations

, , +17

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG

Carolien H. Smorenburg, S.M. de Groot, A. Elise van Leeuwen‐Stok et al. · Annals of Oncology · 2014 · 63 citations · Full text

, , +11

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial

Siu W. Lam, S.M. de Groot, A.H. Honkoop et al. · European Journal of Cancer · 2014 · 31 citations

, , +16

1–3 of 3